Dexmedetomidine and Propofol Sedation in Critically Ill Patients and Dose-Associated 90-Day Mortality
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Dexmedetomidine and Propofol Sedation in Critically Ill Patients and Dose-associated 90-Day Mortality: A Secondary Cohort Analysis of a Randomized Controlled Trial (SPICE III)
Am J Respir Crit Care Med 2023 Apr 01;207(7)876-886, Y Shehabi, A Serpa Neto, R Bellomo, BD Howe, YM Arabi, M Bailey, FE Bass, S Bin Kadiman, CJ McArthur, MC Reade, IM Seppelt, J Takala, MP Wise, SA WebbFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.